BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15561299)

  • 1. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
    Tanaka J; Toubai T; Miura Y; Tsutsumi Y; Kato N; Umehara S; Toyoshima N; Ohta S; Asaka M; Imamura M
    Transplant Proc; 2004 Oct; 36(8):2511-2. PubMed ID: 15561299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
    Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
    Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
    Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
    Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells.
    Sugita J; Tanaka J; Yasumoto A; Shiratori S; Wakasa K; Kikuchi M; Shigematsu A; Kondo T; Asaka M; Imamura M
    Ann Hematol; 2010 Feb; 89(2):115-20. PubMed ID: 19578849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD94 and NKG2 molecules on human CD4(+) T cells in response to CD3-mediated stimulation.
    Romero P; Ortega C; Palma A; Molina IJ; Peña J; Santamaría M
    J Leukoc Biol; 2001 Aug; 70(2):219-24. PubMed ID: 11493613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
    Gunturi A; Berg RE; Crossley E; Murray S; Forman J
    Eur J Immunol; 2005 Mar; 35(3):766-75. PubMed ID: 15714583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
    J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytolytic activity and regulatory functions of inhibitory NK cell receptor-expressing T cells expanded from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells.
    Tanaka J; Toubai T; Tsutsumi Y; Miura Y; Kato N; Umehara S; Kahata K; Mori A; Toyoshima N; Ota S; Kobayashi T; Kobayashi M; Kasai M; Asaka M; Imamura M
    Blood; 2004 Aug; 104(3):768-74. PubMed ID: 15073036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.
    Borrego F; Masilamani M; Kabat J; Sanni TB; Coligan JE
    Mol Immunol; 2005 Feb; 42(4):485-8. PubMed ID: 15607803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CD94/NKG2A--a kind of inhibitory receptor belonging to C-type lectin superfamily].
    Wang Y; Zhu LP; Zhang W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):653-5. PubMed ID: 12905700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
    Arlettaz L; Villard J; de Rham C; Degermann S; Chapuis B; Huard B; Roosnek E
    Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
    Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
    Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.
    Bellón T; Heredia AB; Llano M; Minguela A; Rodriguez A; López-Botet M; Aparicio P
    J Immunol; 1999 Apr; 162(7):3996-4002. PubMed ID: 10201920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cells.
    Lafarge X; Pitard V; Ravet S; Roumanes D; Halary F; Dromer C; Vivier E; Paul P; Moreau JF; Déchanet-Merville J
    Eur J Immunol; 2005 Jun; 35(6):1896-905. PubMed ID: 15864777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.